Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context

Affiliations

• ¹ Cross Cancer Institute, Edmonton, Alberta, Canada; Department of Oncology, University of Alberta, Edmonton, AB, Canada.
• ² Department of Medical Genetics, University of Alberta, Edmonton, AB, Canada.
• ³ Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
• ⁴ Department of Oncology, McMaster University, Hamilton, ON, Canada.
• ⁵ Division of Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
• ⁶ Tom Baker Cancer Centre and Cumming School of Medicine, Calgary, AB, Canada.
• ⁷ BC Cancer Agency and University of British Columbia, Vancouver, BC, Canada.
• ⁸ Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia and Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
• ⁹ Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, QC, Canada.